ABSTRACT
52
Sepsis is a significant cause of morbidity and mortality among critically ill patients and is characterized 53 by overwhelming inflammation in response to infection leading to organ dysfunction. Metabolic dys-54 function characterized by elevations in circulating blood glucose occurs in nearly 12% of cases and is as-55 sociated with increased organ dysfunction, longer hospital stays, and higher mortality (Krinsley 2003, 56 Martin et al. 2003 , Leonidou et al. 2008 , Kyle et al. 2010 . Initial clinical trials in critically ill patients 57 demonstrated mortality benefits with tight glycemic control using intravenous insulin, but subsequent 58 trials failed to show the same benefit and suggested potential harm due to the increased risk of 59 hypoglycemia with insulin infusions to target intensive glucose control (van den Berghe et al. 2001, 60 Brunkhorst et al. 2008 , Finfer et al. 2009 , Ling et al. 2012 ). Of note, septic patients maintaining 61 euglycemia and not requiring supplemental insulin appear to experience improved mortality (Leonidou 62 et al. 2008) . Therefore, developing strategies to prevent the development of hyperglycemia rather than 63 treat it once established may improve morbidity and mortality in sepsis.
64
Nutritional support, particularly early in sepsis, may contribute to glucose elevation and thus adversely D r a f t D r a f t Mice underwent either CLP or sham surgery immediately after implantation of the femoral catheters (total surgical time ~60 min) as previously described (Watanabe et al. 2013) . In brief, an abdominal ver- 
109

Experimental protocol
110
In a block design study of four experimental groups, CLP and sham mice received either intravenous 111 dextrose or intravenous saline infusion for 24 hours immediately following completion of the surgery
112
(Supplementary Figure S1 ). Mice were administered either 25% Dextrose (D25, Hospira, Lake Forest, IL)
113
at 100 µl/hr, approximately 20% of the daily caloric requirements for a 25g mouse, or 0.9% normal sa-114 line (NS) at an equivalent rate. Animal behavior and food intake were monitored during the 24 hr exper-115 imental protocol. Blood glucose, and plasma insulin, corticosterone, and cytokines were measured at 24 116 hours. At the completion of the experimental protocol, mice were euthanized according to AVMA guide-117 lines and pancreatic tissue was harvested for histological analysis and serial dilutions of whole blood 118 were plated, incubated at 37 o C for 24 hr, and bacterial colonies counted.
120
In a second set of experiments, using four comparable experimental groups, hyperinsulinemic-121 euglycemic clamps were performed 22 hr after surgery to assess whole body insulin sensitivity as previ- Table S1 ).
247
DISCUSSION
248
Our study found that early administration of low levels of caloric support in a murine cecal ligation and 249 puncture model of sepsis induced profound glucose intolerance. We observed rapid decompensation in 250 glucose control (within 24 hrs) characterized by profound insulin resistance, deficient insulin secretion,
251
and severe hyperglycemia in septic animals receiving low-level parenteral dextrose resulting in a pheno-
252
type resembling an accelerated form of type 2 diabetes. This pattern mimicked that seen in prior exper-
253
iments with septic mice receiving higher levels of caloric support (Watanabe et al. 2013 ). Thus, our data 
269
ops is ineffective at restoring glucose control.
271
The acuity of metabolic decompensation in our septic mice, and its relationship to activation of pro- 
286
generation of reactive oxygen species (Strowig et al.) . In the pancreas, the combination of low dose IL-287 1β and TNF-α also suppresses insulin production by pancreatic islets (Mehta et al. 1994) , and LPS in-
288
duced IL-1β has been shown to suppress pancreatic beta cell function in vitro (Cruzat et al. 2015 
314
Clinical Implications
315
The recent CALORIES trial (Harvey et al. 2014) suggests that low-level early parenteral nutritional sup- 
326
Conclusions
327
The underlying pathophysiologic and metabolic consequences of low-level early parenteral calorie pro- n=18) or severe hyperglycemia (CLP Dex Sev, ≥600 mg/dl; n=20). Panel B -Plasma insulin levels are similar 24 hrs after sham surgery (Sham Sal, Sham Dex, n ≥ 7) or after CLP in the setting of saline infusion (CLP Sal, n ≥ 6). In contrast, circulating insulin is significantly increased in all CLP mice receiving dextrose (CLP + Dex) compared to CLP Sal mice (p=0.003 by one-way ANOVA). Plasma insulin levels were similar between CLP + Dex mice in Eug, Hyp, and Sev groups (p > 0.05 by one-way ANOVA). Panel C -Plasma insulin levels increase with elevations in blood glucose for CLP Sal and CLP + Dex Eug groups (Slope = 0.045 ± 0.01 (p<0.001 compared to zero, r 2 =0.32). However, for mice in CLP + Dex Hyp and CLP + Dex Sev groups, higher blood glucose levels do not result in corresponding increases in plasma insulin (Slope =-0.009 ± 0.004 (p=0.1 compared to zero, r 2 =0.64). Panel D -Paraffin sections of pancreas stained with hematoxylin and eosin (top panels) demonstrate islets with normal morphology independent of development of hyperglycemia. Immunofluorescence for insulin (green) and activated caspase 3 (red) confirmed that very few beta cells showed signs of apoptotic cell death (bottom panels) in septic mice exposed to dextrose infusion. 90x64mm (300 x 300 DPI) D r a f t Figure 2 -Low-dose parenteral glucose induces marked insulin resistance in septic mice developing severe hyperglycemia. Blood glucose (Panel A) and glucose infusion rates (Panel C) were plotted during hyperinsulinemic euglycemic clamp experiments performed 22 hours after sham or CLP surgery and infusion of either saline or dextrose (Sal, Dex, n ≥ 4 each). Panel B depicts the average glucose infusion rate during the final 30 min of the clamp. In CLP + Dex mice developing severe hyperglycemia (Sev), blood glucose could not be reduced to the euglycemic range (100-110 mg/dl) despite continuous admin-istration of 20 mU/kg/min of insulin. Panel D depicts insulin sensitivity as measured by whole body glu-cose uptake. Insulin sensitivity was approximately 50% of control in CLP Sal and CLP + Dex Eug mice. However, in CLP + Dex Sev mice, whole body glucose uptake was reduced to zero indicating a profoundly insulin resistant state. Data presented as Mean ± SEM. Differences determined by one-way ANOVA with Tukey's post-hoc analysis. 101x81mm (300 x 300 DPI) D r a f t Figure 3 -The development of hyperglycemia in septic mice exposed to dextrose infusion is associated with increased inflammatory cytokines. Panel A -CLP increased pro-inflammatory IL-1β secretion compared to sham surgery (CLP Sal vs. Sham Sal, p=0.01). IL-1β levels increased in mice developing hy-perglycemia in the setting of CLP and dextrose infusion (CLP + Dex Hyp, BG=200-599 mg/dl and CLP + Dex Sev, BG≥ 600 mg/dl) compared to saline controls or CLP + Dex mice maintaining euglycemia (Eug, BG<200 mg/dl). Similar patterns were noted for the cytokines IL-18, TNF-α, IL-6, and IL-10 (Panels B, C, D, and E). Data presented as Mean ± SEM (Sham n≥9, CLP n≥7). Differences determined by one-way ANOVA with Tukey's or Dunnett's post-hoc analyses as appropriate. 126x127mm (300 x 300 DPI)
